BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29325133)

  • 21. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
    Chou KH; von Eye Corleta H; Capp E; Spritzer PM
    Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study.
    Elkind-Hirsch KE; Paterson MS; Seidemann EL; Gutowski HC
    Fertil Steril; 2017 Jan; 107(1):253-260.e1. PubMed ID: 28228317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
    Moghetti P; Castello R; Negri C; Tosi F; Perrone F; Caputo M; Zanolin E; Muggeo M
    J Clin Endocrinol Metab; 2000 Jan; 85(1):139-46. PubMed ID: 10634377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome.
    Glueck CJ; Goldenberg N; Wang P
    J Pediatr Endocrinol Metab; 2009 Sep; 22(9):815-26. PubMed ID: 19960891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.
    Yilmaz M; Karakoç A; Törüner FB; Cakir N; Tiras B; Ayvaz G; Arslan M
    Gynecol Endocrinol; 2005 Sep; 21(3):154-60. PubMed ID: 16335907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.
    Loverro G; Lorusso F; De Pergola G; Nicolardi V; Mei L; Selvaggi L
    Gynecol Endocrinol; 2002 Jun; 16(3):217-24. PubMed ID: 12192894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment.
    Velija-Ašimi Z
    Bosn J Basic Med Sci; 2013 Aug; 13(3):180-5. PubMed ID: 23988170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin versus lifestyle changes in treating women with polycystic ovary syndrome.
    Curi DD; Fonseca AM; Marcondes JA; Almeida JA; Bagnoli VR; Soares JM; Baracat EC
    Gynecol Endocrinol; 2012 Mar; 28(3):182-5. PubMed ID: 22309675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS).
    Glueck CJ; Wang P; Fontaine R; Tracy T; Sieve-Smith L
    J Adolesc Health; 2001 Sep; 29(3):160-9. PubMed ID: 11524214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the individual effects of metformin and rosiglitazone and their combination in obese women with polycystic ovary syndrome: a randomized controlled trial.
    Li Y; Tan J; Wang Q; Duan C; Hu Y; Huang W
    Fertil Steril; 2020 Jan; 113(1):197-204. PubMed ID: 31718828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women With PCOS.
    Xing C; Li C; He B
    J Clin Endocrinol Metab; 2020 Sep; 105(9):2950-63. PubMed ID: 32490533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.
    Gambineri A; Pelusi C; Genghini S; Morselli-Labate AM; Cacciari M; Pagotto U; Pasquali R
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):241-9. PubMed ID: 14725687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of metformin treatment and laparoscopic ovarian diathermy in patients with polycystic ovary syndrome.
    Ashrafinia M; Hosseini R; Moini A; Eslami B; Asgari Z
    Int J Gynaecol Obstet; 2009 Dec; 107(3):236-9. PubMed ID: 19729161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does Metformin Treatment During Pregnancy Modify the Future Metabolic Profile in Women With PCOS?
    Underdal MO; Stridsklev S; Oppen IH; Høgetveit K; Andersen MS; Vanky E
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2408-2413. PubMed ID: 29659896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised controlled trial to study the efficacy of exercise with and without metformin on women with polycystic ovary syndrome.
    Tiwari N; Pasrija S; Jain S
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():149-154. PubMed ID: 30690191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomised double-blind study.
    Hanjalic-Beck A; Gabriel B; Schaefer W; Zahradnik HP; Schories M; Tempfer C; Keck C; Denschlag D
    Gynecol Endocrinol; 2010 Sep; 26(9):690-7. PubMed ID: 20626240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
    Kilicdag EB; Bagis T; Zeyneloglu HB; Tarim E; Aslan E; Haydardedeoglu B; Erkanli S
    Hum Reprod; 2005 Apr; 20(4):894-9. PubMed ID: 15618250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome.
    Oner G; Muderris II
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):127-31. PubMed ID: 21831508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome.
    Palomba S; Falbo A; Russo T; Manguso F; Tolino A; Zullo F; De Feo P; Orio F
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3128-35. PubMed ID: 17519312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.